FDCDDQ
TEVA icon

Federation des caisses Desjardins du Quebec’s Teva Pharmaceuticals TEVA Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8M Buy
317,729
+32,106
+11% +$1.07M 0.03% 346
2026
Q1 		$8.6M Buy
285,623
+16,945
+6% +$545K 0.03% 332
2025
Q4 		$8.39M Buy
268,678
+2,912
+1% +$71.7K 0.03% 326
2025
Q3 		$5.37M Buy
265,766
+14,511
+6% +$255K 0.02% 396
2025
Q2 		$4.21M Sell
251,255
-23,657
-9% -$382K 0.02% 434
2025
Q1 		$4.23M Buy
274,912
+4,416
+2% +$78.9K 0.02% 393
2024
Q4 		$5.96M Buy
270,496
+15,239
+6% +$277K 0.03% 311
2024
Q3 		$4.6M Sell
255,257
-10,198
-4% -$178K 0.02% 365
2024
Q2 		$4.31M Buy
265,455
+130,363
+96% +$2.01M 0.02% 360
2024
Q1 		$1.79M Buy
135,092
+49,475
+58% +$624K 0.01% 552
2023
Q4 		$894K Sell
85,617
-5,990
-7% -$55.9K 0.01% 669
2023
Q3 		$934K Sell
91,607
-6,196
-6% -$57.7K 0.01% 602
2023
Q2 		$736K Buy
97,803
+6,527
+7% +$52.9K 0.01% 682
2023
Q1 		$808K Sell
91,276
-17,419
-16% -$172K 0.01% 649
2022
Q4 		$991K Sell
108,695
-974
-0.9% -$8.5K 0.01% 570
2022
Q3 		$885K Sell
109,669
-2,400
-2% -$21.2K 0.01% 608
2022
Q2 		$843K Buy
112,069
+22,744
+25% +$198K 0.01% 642
2022
Q1 		$839K Sell
89,325
-2,779
-3% -$23.2K 0.01% 699
2021
Q4 		$738K Sell
92,104
-998
-1% -$9.01K 0.01% 743
2021
Q3 		$907K Sell
93,102
-3,055
-3% -$28.6K 0.01% 718
2021
Q2 		$952K Sell
96,157
-9,749
-9% -$103K 0.01% 721
2021
Q1 		$1.22M Buy
105,906
+4,324
+4% +$49.6K 0.01% 621
2020
Q4 		$980K Sell
101,582
-170,937
-63% -$1.64M 0.01% 639
2020
Q3 		$2.46M Buy
272,519
+13,709
+5% +$145K 0.03% 346
2020
Q2 		$3.19M Sell
258,810
-209,557
-45% -$2.37M 0.05% 286
2020
Q1 		$4.21M Sell
468,367
-17,377
-4% -$178K 0.07% 199
2019
Q4 		$4.76M Buy
485,744
+2,199
+0.5% +$19.6K 0.07% 229
2019
Q3 		$3.33M Buy
483,545
+106,341
+28% +$815K 0.05% 288
2019
Q2 		$3.48M Buy
377,204
+150,839
+67% +$1.82M 0.05% 284
2019
Q1 		$3.55M Buy
226,365
+22,652
+11% +$399K 0.05% 268
2018
Q4 		$3.14M Buy
203,713
+11,115
+6% +$228K 0.05% 286
2018
Q3 		$4.15M Sell
192,598
-2,404
-1% -$55.8K 0.06% 259
2018
Q2 		$4.74M Sell
195,002
-44,489
-19% -$907K 0.07% 242
2018
Q1 		$4.09M Buy
239,491
+33,287
+16% +$650K 0.06% 262
2017
Q4 		$3.91M Buy
206,204
+6,548
+3% +$98.5K 0.06% 265
2017
Q3 		$3.51M Buy
199,656
+31,763
+19% +$715K 0.06% 271
2017
Q2 		$5.58M Buy
167,893
+5,260
+3% +$163K 0.09% 201
2017
Q1 		$5.22M Buy
+162,633
New +$5.55M 0.1% 181

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's TEVA Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Teva Pharmaceuticals (TEVA) stake by 11% in Q2 2026, buying an estimated $1.07M and bringing the position to 317,729 shares worth $10.8M. The position accounts for 0.03% of the portfolio, ranked #346.

Federation des caisses Desjardins du Quebec first reported a position in TEVA in Q1 2017 and has held it in 38 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 317,729 shares of Teva Pharmaceuticals worth $10.8M as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 32,106 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.07M.
  • Teva Pharmaceuticals made up 0.03% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #346 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Teva Pharmaceuticals in Q1 2017 and has held it in 38 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.